We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Clearwater Paper
CLW
$366M
| $335K | ﹤0.01% |
11,944
-16,182
| -58% | -$508K |
|
2777
Rimini Street
RMNI
$449M
| $335K | ﹤0.01% |
+57,734
| New | +$303K |
|
2778
Franklin Covey
FC
$235M
| $334K | ﹤0.01% |
7,378
-1,202
| -14% | -$55.7K |
|
|
PRDS
2779
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $334K | ﹤0.01% |
46,300
+44,094
| +1,999% | +$434K |
|
|
EVOJU
2780
DELISTED
Evo Acquisition Corp. Unit
EVOJU
| $334K | ﹤0.01% |
+33,912
| New | +$336K |
|
2781
Atomera
ATOM
$217M
| $333K | ﹤0.01% |
+25,489
| New | +$382K |
|
|
ML
2782
DELISTED
MoneyLion Inc.
ML
| $333K | ﹤0.01% |
4,427
-379
| -8% | -$29.6K |
|
|
PFC
2783
DELISTED
Premier Financial Corp. Common Stock
PFC
| $332K | ﹤0.01% |
10,950
-2,488
| -19% | -$76.5K |
|
2784
Millicom
TIGO
$15.9B
| $331K | ﹤0.01% |
+13,126
| New | +$338K |
|
2785
AtaiBeckley Inc
ATAI
$2.67B
| $330K | ﹤0.01% |
64,742
-4,897
| -7% | -$27.2K |
|
|
WOW
2786
DELISTED
WideOpenWest
WOW
| $330K | ﹤0.01% |
18,930
-2,414
| -11% | -$44.8K |
|
2787
Global Net Lease
GNL
$1.91B
| $329K | ﹤0.01% |
20,922
-61,992
| -75% | -$911K |
|
|
TDAY
2788
USA Today Co
TDAY
$1B
| $328K | ﹤0.01% |
72,634
+51,573
| +245% | +$262K |
|
2789
Daktronics
DAKT
$1.02B
| $327K | ﹤0.01% |
85,277
+31,836
| +60% | +$146K |
|
|
RPC
2790
Ridgepost Capital
RPC
$976M
| $327K | ﹤0.01% |
26,992
+5,941
| +28% | +$73.9K |
|
|
ALBO
2791
DELISTED
Albireo Pharma Inc
ALBO
| $327K | ﹤0.01% |
10,975
+10,006
| +1,033% | +$293K |
|
2792
Artivion
AORT
$1.38B
| $325K | ﹤0.01% |
+15,182
| New | +$293K |
|
2793
Perimeter Solutions
PRM
$5.65B
| $325K | ﹤0.01% |
+26,800
| New | +$337K |
|
2794
Dr. Reddy's Laboratories
RDY
$10.4B
| $325K | ﹤0.01% |
29,140
+10,915
| +60% | +$124K |
|
|
PEGR
2795
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $325K | ﹤0.01% |
+33,417
| New | +$324K |
|
|
ACH
2796
DELISTED
Alum Corp of China Ltd
ACH
| $325K | ﹤0.01% |
22,470
-5,971
| -21% | -$90.9K |
|
2797
Dana Inc
DAN
$3.27B
| $324K | ﹤0.01% |
18,448
+447
| +2% | +$9.14K |
|
|
DRD
2798
DRDGold
DRD
$2.07B
| $323K | ﹤0.01% |
34,508
-23,318
| -40% | -$207K |
|
|
SOND
2799
DELISTED
Sonder
SOND
| $323K | ﹤0.01% |
+3,395
| New | +$487K |
|
|
INBX
2800
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $323K | ﹤0.01% |
14,500
+4,200
| +41% | +$107K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.